← Back to Search

HPV Vaccination Strategies for Cancer Prevention

N/A
Recruiting
Led By Parth Shah
Research Sponsored by Fred Hutchinson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
AIM II: Patients must be >= 18 years old
AIM I: Patients must be >= 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-test implementation survey (at months 4-5) and post- test implementation survey (at months 11-12)
Awards & highlights

Study Summary

This trial aims to make it easier for parents to get HPV vaccinations for their adolescents at pharmacies, which may reduce the risk of cancer caused by HPV.

Who is the study for?
This trial is for pharmacy staff in Washington state, parents of children aged 9-17 who have had an HPV vaccine at a participating pharmacy, and employees of STCHealth and PioneerRx. Participants must be over 18 years old and have internet access or a phone.Check my eligibility
What is being tested?
The study is developing a Clinical Decision Support (CDS) tool to increase HPV vaccination rates among adolescents in pharmacies. It involves discussions, educational activities, healthcare interventions, and surveys to see if the CDS tool makes getting vaccines easier.See study design
What are the potential side effects?
Since this trial focuses on the use of decision support tools rather than medical treatments or drugs, there are no direct side effects related to medications. However, participants may experience inconvenience or time commitment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-test implementation survey (at months 4-5) and post- test implementation survey (at months 11-12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-test implementation survey (at months 4-5) and post- test implementation survey (at months 11-12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of CDS tools: Pharmacy staff (Aim II)
Acceptability of pharmacy-based HPV vaccination: Parents (Aim II)
Appropriateness of CDS tools: Pharmacy staff (Aim II)
+10 more
Secondary outcome measures
Rate of other adolescent vaccinations per pharmacist at each pharmacy (Aim II)

Trial Design

3Treatment groups
Experimental Treatment
Group I: Group III (parent survey)Experimental Treatment1 Intervention
Parents complete survey post-intervention on study.
Group II: Group II (staff CDS tool utilization)Experimental Treatment3 Interventions
Staff receives CDS tools training and implements CDS tools to facilitate HPV vaccination on study.
Group III: Group I (staff focus group)Experimental Treatment2 Interventions
Staff participate in facilitated planning discussions to develop CDS tools on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Healthcare Activity
2021
N/A
~50

Find a Location

Who is running the clinical trial?

Fred Hutchinson Cancer CenterLead Sponsor
556 Previous Clinical Trials
1,343,102 Total Patients Enrolled
16 Trials studying Carcinoma
961 Patients Enrolled for Carcinoma
Parth ShahPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium
4 Previous Clinical Trials
864 Total Patients Enrolled

Media Library

Healthcare Activity Clinical Trial Eligibility Overview. Trial Name: NCT05831540 — N/A
Carcinoma Research Study Groups: Group I (staff focus group), Group II (staff CDS tool utilization), Group III (parent survey)
Carcinoma Clinical Trial 2023: Healthcare Activity Highlights & Side Effects. Trial Name: NCT05831540 — N/A
Healthcare Activity 2023 Treatment Timeline for Medical Study. Trial Name: NCT05831540 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total sample size of this clinical trial?

"Affirmative. According to the information on clinicaltrials.gov, this medical experiment is presently seeking participants and was initially publicized on May 14th 2023 with its last update occurring April 26th 2023. The study requires 114 individuals from one location to take part in it."

Answered by AI

Is recruitment for this experiment still in progress?

"Yes, clinicaltrials.gov attests that this medical inquiry is presently enrolling participants. It was initially posted on May 14th 2023 and has since been reconfirmed on April 26th of the same year. A total of 114 patients must be recruited from only one site."

Answered by AI
~NaN spots leftby Mar 2024